Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Rubius Therapeutics Inc.

    NASDAQ: RUBY · Real-Time Price · USD
    0.06
    0.00 (8.11%)
    At close: Dec 29, 2023, 9:49 PM

    Rubius Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 14.87M 225.85M
    Short-Term Investments
    		 4.07M n/a
    Long-Term Investments
    		 n/a n/a
    Other Long-Term Assets
    		 50K 1.57M
    Receivables
    		 n/a n/a
    Inventory
    		 n/a n/a
    Other Current Assets
    		 1.26M 3.98M
    Total Current Assets
    		 20.2M 229.82M
    Property-Plant & Equipment
    		 2.83M 86.63M
    Goodwill & Intangibles
    		 n/a n/a
    Total Long-Term Assets
    		 2.88M 88.2M
    Total Assets
    		 23.07M 318.02M
    Account Payables
    		 1.23M 11.57M
    Deferred Revenue
    		 n/a 13.4M
    Short-Term Debt
    		 1.1M 9.02M
    Other Current Liabilities
    		 5.61M 14.07M
    Total Current Liabilities
    		 7.94M 34.66M
    Long-Term Debt
    		 n/a 104.44M
    Other Long-Term Liabilities
    		 n/a 135K
    Total Long-Term Liabilities
    		 n/a 104.58M
    Total Liabilities
    		 7.94M 139.24M
    Total Debt
    		 1.1M 113.46M
    Book Value
    		 n/a n/a
    Book Value Per Share
    		 n/a n/a
    Common Stock
    		 90K 90K
    Retained Earnings
    		 -856.68M -677.02M
    Comprehensive Income
    		 n/a n/a
    Shareholders Equity
    		 15.13M 178.78M
    Total Investments
    		 4.07M n/a

    Add to Watchlist